Talphera Inc
F:R5XA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Talphera Inc (R5XA) under the Base Case is EUR per share.
Compared with the current market price of 0.94 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Talphera Does
Talphera is a specialty pharmaceutical company focused on acute care, especially pain control and sedation in hospital and other closely monitored medical settings. It develops and commercializes prescription drug products designed for use by clinicians, where fast onset, controlled dosing, and simple administration matter more than everyday retail convenience.
- Headquarters
- United States of America US
- Employees
- 12
- IPO date
- Feb 11, 2011
Revenue & Expenses Breakdown
Talphera Inc
Earnings Waterfall
Talphera Inc
What is the Intrinsic Value of one R5XA stock?
The intrinsic value for Talphera Inc (R5XA) under the Base Case is EUR.
Is R5XA stock undervalued or overvalued?
Compared with the current market price of 0.94 EUR, the stock appears .
